A study of complement fixation by rheumatoid factor using a haemolytic assay system.
Complement fixation by rheumatoid factor (RF) in sera from rheumatoid arthritis patients has been investigated by means of a haemolytic assay system employing sheep erythrocytes (SRBC) coated with reduced and alkylated rabbit IgG anti-SRBC antibody. Haemolysis was almost invariably detected with RF-positive sera whereas haemolysis was not observed with RF-negative sera; It was evident from a marked increase in haemolysis, obtained following isolation of IgM-RF of high purity from several RF-positive sera, that the full in vitro complement-fixing ability and hence lytic potential of RF in serum is masked. Parallel observations were also made with synovial fluids. The inhibition of haemolysis by RF in sera and synovial fluids commonly involved a reduction in degree of lysis at high concentration of test material as well as a more generalized inhibition in overall percentage lysis. Complete replication of typical RF-positive serum and synovial fluid patterns of lysis on dilution was achieved by addition of heat-aggregated human IgG to isolated IgM-RF preparations and demonstrated that the two inhibitory effects are separable in terms of complement depletion and reduction of free rheumatoid factor antibody activity, respectively.
D001172:Arthritis, Rheumatoid / Q000276:immunology; D003168:Complement Fixation Tests; D004912:Erythrocytes / Q000276:immunology; D006461:Hemolysis; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012217:Rheumatoid Factor / Q000302:isolation & purification; D013582:Synovial Fluid / Q000276:immunology
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012217:Rheumatoid Factor